Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2005-2017

  Duangjit, Sureewan ^a,b   Pamornpathomkul, Boonnada ^a   Opanasopit, Praneet ^a   Rojanarata, Theerasak ^a   Obata, Yasuko ^b   Takayama, Kozo ^b   Ngawhirunpat, Tanasait ^a  

^a SILPAKORN UNIVERSITY   (Thailand)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

Optimal liposome; Optimization; Surfactant carbon chain length; Surfactant charge; Surfactant content; Transdermal drug delivery

Indexed keywords

ANIONIC SURFACTANT; CATIONIC SURFACTANT; LIPOSOME; MELOXICAM; CARBON; NANOCAPSULE; NONSTEROID ANTIINFLAMMATORY AGENT; SURFACTANT; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ARTICLE; CARBON CHAIN LENGTH; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG STRUCTURE; ELASTICITY; ENTRAPMENT EFFICIENCY; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIPOSOMAL DELIVERY; NONHUMAN; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; PROCESS OPTIMIZATION; SKIN PENETRATION; SKIN PERMEABILITY; VESICLE SIZE; ZETA POTENTIAL; ANIMAL; CHEMISTRY; ELAPIDAE; INTRADERMAL DRUG ADMINISTRATION; MOLECULAR WEIGHT; PARTICLE SIZE; PHYSIOLOGY; SKIN ABSORPTION; STATIC ELECTRICITY; ULTRASTRUCTURE;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARBON; ELAPIDAE; LIPOSOMES; MOLECULAR WEIGHT; NANOCAPSULES; PARTICLE SIZE; SKIN ABSORPTION; STATIC ELECTRICITY; SURFACE-ACTIVE AGENTS; THIAZINES; THIAZOLES;

EID: 84899800394     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S60674     Document Type: Article

References (38)

1. Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzer C. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res. 1995;44:423-433.
2. Luger P, Daneck K, Engel W, Trummlitz G, Wagner K. Structure and physicochemical properties of meloxicam, a new NSAID. Eur J Pharm Sci. 1996;4:175-187.
3. Degner F, Sigmund R, Zeidler H. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease. Clin Ther. 2000;22:400-410.
4. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993;104(6):1832-1847.
5. Yuan Y, Li SM, Mo FK, Zhong DF. Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm. 2006;321: 117-123.
6. Jantharaprapap R, Stagni G. Effects of penetration enhancers on in vitro permeability of meloxicam gels. Int J Pharm. 2007;343:26-33.
7. Cevc G, Schätzlein A, Blume G. Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J Control Release. 1995;36:3-16.
8. Montenegro L, Panico AM, Ventimiglia A, Bonina FP. In vitro retinoic acid release and skin permeation from different liposome formulations. Int J Pharm. 1996;133:89-96.
9. Katahira N, Murakami T, Kugai S, Yata N, Takano M. Enhancement of topical delivery of a lipophilic drug from charged multilamellar liposomes. J Drug Target. 1999;6:405-414.
10. Mohammed AR, Weston N, Coombes AG, Fitzgerald M, Perrie Y. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm. 2004;285:23-34.
11. Song YK, Kim CK. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials. 2006;27(2):271-280.
12. Sinico C, Manconi M, Peppi M, Lai F, Valenti D, Fadda AM. Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. J Control Release. 2005;103: 123-136.
13. Manosroi A, Khanrin P, Lohcharoenkal W, etal. Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm. 2010;392:304-310.
14. Gillet A, Compère P, Lecomte F, etal. Liposome surface charge influence on skin penetration behaviour. Int J Pharm. 2011;411:223-231.
15. Takayama K, Nagai T. Simultaneous optimization for several characteristics concerning percutaneous absorption and skin damage of ketoprofen hydrogels containing d-limonene. Int J Pharm. 1991;74(2-3): 115-126.
16. Ueda N, Nakano R. Estimating expected error rates of neural network classifiers in small sample size situations: a comparison of cross-validation and bootstrap. IEEE International Conference Neural Networks Proceeding; 27 Nov 1995-01 Dec 1995, 1995; Perth, WA.
17. Dupret G, Koda M. Bootstrap resampling for unbalanced data in supervised learning. Eur J Oper Res. 2001;134:141-156.
18. Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J Drug Deliv. 2011;2011:418316.
19. Shotton DM, Servers NJ. An introduction to freeze fracture and deep etching. In: Servers NJ, Shotton DM, editors. Rapid freezing, freeze fracture, and deep etching. New York: Wiley-Liss; 1995:1-31.
20. Cevc G. Material Transport Across Permeability Barriers by Means of Lipid Vesicles. In: Lipowsky R, Sackmann E, editors. Handbook of Biological Physics. Amsterdam: Elsevier; 1995:465-490.
21. Ngawhirunpat T, Panomsuk S, Opanasopit P, Rojanarata T, Hatanaka T. Comparison of the percutaneous absorption of hydrophilic and lipophilic compounds in shed snake skin and human skin. Pharmazie. 2006;61:331-336.
22. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm. 2007;332:1-16.
23. Fang YP, Tsai YH, Wu PC, Huang YB. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int J Pharm. 2008(356):144-152.
24. Ali MH, Moghaddam B, Kirby DJ, Mohammed AR, Perrie Y. The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs. Int J Pharm. 2013;453(1):225-232.
25. Park SI, Lee EO, Kim JW, Kim YJ, Han SH, Kim JD. Polymer-hybridized liposomes anchored with alkyl grafted poly(asparagine). J Colloid Interface Sci. 2011;364:31-38.
26. Dan N. Lipid tail chain asymmetry and the strength of membrane-induced interactions between membrane proteins. Biochim Biophys Acta. 2007;1768:2393-2399.
27. Liu J, Zou A, Mu B. Surfactin effect on the physicochemical property of PC liposome. Colloids Surf A Physicochem Eng Asp. 2010;361:90-95.
28. Barry BW. Penetration enhancer classification. In: Smith, Maibach HI, editors. Percutaneous Penetration Enhancers. 2nd ed. Boca Raton, FL: CRC Press; 2006:3-15.
29. Williams AC. Transdermal and Topical Drug Delivery: From Theory to Clinical Practice. London: Pharmaceutical Press; 2003.
30. Ashton P, Walters KA, Brain KR, Hadgraft J. Surfactant effects in percutaneous absorption. I. Effects on the transdermal flux of methyl nicotinate. Int J Pharm. 1992;87:261.
31. Aungst BJ, Rogers NJ, Shefter E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int J Pharm. 1986;33:225-234.
32. Ogiso T, Shintani M. Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. J Pharm Sci. 1990;79:1065.
33. Liu D, Chen W, Tsai L, Yang S. Microcalorimetric and shear studies on the effects of cholesterol on the physical stability of lipid vesicles. Colloids Surf A Physicochem Eng Asp. 2000;172:57-67.
34. Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm. 2005;300:95-101.
35. Kato A, Ishibashi Y, Miyake Y. Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride. J Pharm Pharmacol. 1987;39:399-400.
36. Zellmer S, Pfeil W, Lasch J. Interaction of phosphatidylcholine liposomes with the human stratum corneum. Biochim Biophys Acta. 1995;1237:176-182.
37. Kirjavainen M, Urtti A, Jääskeläinen I, etal. Interaction of liposomes with human skin in vitro-the influence of lipid composition and structure. Biochim Biophys Acta. 1996;1304:179-189.
38. Obata Y, Utsumi S, Watanabe H, etal. Infrared spectroscopic study of lipid interation in stratum corneum treated with transdermal absorption enhancers. Int J Pharm. 2010;389:18-23.